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A comparison of BHllvancomycin agar. VITEK. and Kirby-Bauer disk. diffusion
methodologies for identifying vancomycin resistance in Enterococcal isolates was
conducted. One hundred-six Enterococcal isolates were collected from several
clinical sites in the Northern Illinois region and tested to determine vancomycin
susceptibility by each of the three methodologies. Of the 106 isolates tested. 23 were
determined by the BHllvancomycin agar method to be vancomycin resistant and 83
were determined to be vancomycin susceptible. VITEK correctly identified all of the 83
vancomycin susceptible isolates (100%) and 20 of the 23 vancomycin resistant
isolates (87%). Kirby-Bauer disk. diffusion cooectly identified all of the 83 vancomycin
susceptible isolates (100%) and 22 of the 23 vancomycin resistant isolates (95.6%).
The sensitivity and specificity of each of the three methodologies evaluated in this
study are quite high; however. whether or not these values justify using only VITEK or
Kirby-Bauer susceptibility testing without a confirmatory method can not be determined
by this rather limited study alone. These results do confirm that incorrect susceptibility
testing results occur with both VITEK and Kirby-Bauer methodologies, particularly in
determining vancomycin resistance. Until additional studies confirm that automated
MIC determination Q" Kirby-Bauer susceptibility testing consistently give reliable
results. confirmatory testing with BHllvancomycin agar plates will ensure that accurate
vancomycin susceptibility results are reported for Enterococcal isolates.
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Purpose The purpose of this project is to compare the following three
methodologies for identifying vancomycin resistance in enterococcal isolates from
laboratory'specimens: BHllvancomycin agar, VITEK, and Kirby-Bauer disk diffUSion.
8act~ound and literature Review In 1979, U.S. Surgeon General
William Stewart pronounced that it was time to "close the books on InfectiouS
diseases" (Lang. 1994). In the SIxteen short years since then, however, the United
States has seen a steady inaease in the number of Infectious disease cases (lang
1994). One has only to open a local newspaper or weekly news magazine to learn of
intectious disease outbreaks such as CryptosptYIdilim in the Milwaukee water supply.
£. coli 0157: find in hamburger. or bantavrus in the Southwest. These same news
sources print reports from the Centers for Disease Control and Prevention which
portend the emergence of "super bugs" as a consequence of mlaoblal resistance to
the antibiotic ctugs we assumed would be able to treat any infection (Derlot, 1991).
Enterococc are one genus of bacteria that are emerging with multi-aug
resistance .. Treated effectively In the past with a combination of a beta lactam and an
amtnoglycoslde (ampicillin and gentamicin, for example), strains of Enterococci are
now resistant to beta lactams, amlnoglycosides, and even to the glycopeptldes (such
as vancomycin) (Boyle. 1993 Handwerger, 1993 Eliopoulos, 1993). Treatment for
patients Infected with Vancomycin resistant Enterococci (VRE) is relegated to
unproven combinations of antlmlcrobials or to experimental compounds (Nosocomel.
1993). The disheartening result for physicians is that most of these patients die
deSpite antlmlaobial therapy.
While media reports serve to educate the public concerning the Importance of
rapid identification of disease outbreaks, there is a problem facing chnlcal laooratcnes
that may undermine such efforts. The problem is one of reliability. Methods currently
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In use tor detection of antimicrobIal susceptibility have been shown to Qlve erroneous
results for some bacterial species (Centers for Disease Control, 1994). This leads to
inappropriate reporting of <tugs that should be effective and subsequent failure of
treatment. Patients remain infected with resistant bacteria, becoming more and more
critical. while other colonizing bacteria become resistant through exposure to
antimicrobials. Then a downward spiral of disease spread, resistance transfer to other
bacteria, and increased resistance to multiple <tugs ensues.
In light of these cases of infection with resistant bacteria, clinicallaboratorians
and physicians must be able to rely on the methods used for antimlcrobral
susceptibility testing; therefore, it is necessary to test the methods currently in use in
order to modIfy testing methodology as necessary. In the case of vancomycin
resistance In Enterococci, the federal government has recently mandated confirmation
ot aUautomated enterococcal susceptlbtllty testing stating that, "...vancomycln
resistance. In particular moderate vancomycin resistance (as manifested In the vanB
phenotype), is not detected consistently with the automated methods used in many
chmcallaboratorles" (Centers for DIsease Control. 1994). According to the Hospital
Infection Control Practices Advisory Committee, Vancomycin resistance must be
confirmed on all enterococcal isolates from clinical specimens by one of the following
methods: 1) BHI agar with 6 ~glml vancomycin - any growth indicates resistance, or
2) Determination of Minimum Inhibitory Concentration (MIC) by agar dilution. broth
macrodilution. or manual broth microdilution (Centers for Disease Control. 1994).
Although the federal government has mandated confirmatory testing for all
Enterococcal isolates, there have been very few studies documenting the efficacy or
inefficacy of the susceptibility determination methods commonly in use. To my
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knowledge, there has been only one recent study that evaluated VITEK (software
version 7.1) and Kirby-Bauer disk diffusion methodologies (Willey, 1993).
Furthermore, I am not aware of any published results from studies completed on the
utility of BHl/vancomycin agar, although a study is being conducted by the National
Committee for Clinical laboratory Standards (NCClS) (Nosocomial, 1993). It is the
Intent of thiS study, then, to adctess the apparent lack of substantiating evidence by
simultaneously determining the susceptibtllty of one hun<ted-six enterococcal Isolates
With VITEK. BHllvancomycln agar, and Kirby-Bauer disk diffUSIonmethods. ThIS study
WIll evaluate the rehablllty of the VITEK auto analyzer in identifYing vancomycin
resistance m enterccoccal isolates and, subsequently, will examine the need for
confirmatory testmg.
Characteristics of Enterococci The genus Enterococcus is part of the
family Streptococcaceae and includes members of the previous g-oup D StreptocOCCI
(Konema.n. 1992). The EnterococcI are characterized as multiple <tug resistant gram
positive cocci which typically form gray colonies that may be alpha, beta, or gamma
hemolytic on blood agar. Enterococci can be differentiated from other members of the
family Streptococcaceae because they are PYR positive, bile esculin posmve. and
grow in 5% sodium chloride. Bacteria of the genus Enterococcus are found as
normal flora in the human gastrOintestinal tract; however, due to their inaeasing
resstance to antibiotics, the Enterococci are becoming inaeasingly more important as
human pathogens. The Enterococci are capable of causing both nosocomial
(hospital-acquired) and community-acquired infections including endocarditis,
bacteremia, gastroenteritis, neonatal sepsis, and urinary tract and wound infections
(Koneman, 1992). Boyle states that the EnterococcI have become the second most
common cause of nosocomial Infections in the past six years (Boyle, 1993).
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The species most often associated with human infections are Enterococcus
laeca/is and Enterococcus laec/um (Koneman, 1992). E. faecahs is the most
common Isolate and causes 80-90% of enterococcal Infections, while E. falcum
causes 10-15% of Infections and is more resistant to both aminoglycoslde and beta
lactam <:tugs. Other enterococcal species rarely cause infections in humans but may
cause infections in immunocompromised patients (Koneman, 1992).
Mechanisms of Antimicrobial Resistance in Enterococci Vancomycin
belongs to a class of antimicrobial <:tugs known as the glycopeptides, which act to
inhibit bacterial cell wall synthesis (Koneman,1992). Enterococci may display two
mechanisms of antimicrobial resistance: 1) production of inactivation enzymes such
as beta lactamases or 2) ribosomal resistance which alters the aug binding site on the
bacterial cell wall (Koneman, 1992). The gene for vancomycin resistance is thought
to be carned on a transposon and produces altered peptidoglycan precursors, the
most Important of which seems to be D-alantne-D-Iactate. This precursor is coded for
Instead of the normal D-alantne-D-alantne and has a binding afflntty for vancomycin
whIch IS >1000 nrnes lower than the normal peptidoglycan (Eliopoulos. 1993)
Transposons carry plasrruds, which are portions of genetic materiel. from one
bactenum to another during conJugation. nus exchange of genetic material may occur
between bacteria of different strain, species, or genus; thus allowing for development
of vancomycin resistance in streptococci or other pathogens (Koneman. 1992).
For ease in description. the vancomycin resistance patterns of EnterococcI have
been divided into the following three g"oups: 1) vanA - high level. inducible resistance
to both vancomycin and teicoplanin (both glycopeptide antimicrobials) which is carried
on a transposon; 2) vanS - moderate to high level resistance to vancomycin, also
carried on a chromosome, but susceptibility to teicoplanin; and 3) vane - intrinsic low
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level vancomycin resistance (Boyce. 1994). E. faecalis and E. faecium may display
either vanA or vanB resistance while vanC resistance is more typical of E. galhnarum
and E. casseliflavus (Boyce, 1994). let us now examine some manifestations of
vancomycin resistance in enterococcal infections in the United States.
The CDC's National Nosocomial Infection Surveillance system (NNIS) has
compiled some statistics outlining the rapid increase in the number of VRE infecttons
in the United States. These numbers demonstrate the magnitude of the crisis
phYSicians face In treating patients with VRE and also support the need for accurate
susceptlblhty testing in order to Impede the spread of resistance. The percent of
nosocomial VRE infections In the general patient population reported to the CDC
Increased from 0.3% in 1989 to 7.9% in 1993. while the percent of VRE cases among
intensive care Unit pauents increased trom 0.4% In 1989 to 13.6% In 1993
(Nosocomial, 1993). [Table 11The mortality figures for panents with VRE septicemia
versus patients wIth vancomycin susceptible enterococcal sepncerma were 36 6% and
16.4% mortality. respectively (Nosocomial, 1993). Interestlngly. higher numbers of
nosocomial VRE Infections were reported from university affiliated hospitals than trom
non-teaching sites (Nosocomial, 1993).
Incidents of nosocomial VRE outbreaks are well documented (Handwerger.
1993 Boyce, 1994). One particularly interesting incident will illustrate the rapid
dtssemination of vancomycin resistance among patient g-oups. Chow. et aI.,
evaluated the DNA of thirty-eight VRE isolates from patients in five hospitals in three
states and found one strain to be common among four patients in hospital B. located in
Chicago. illinOIS,three patients in hospital A, also In Chicago, and two panents in
hospItal C. located In Detroit, Michigan (ChOW,1993). [Figure 11 With eVIdence of
enterococcal spread as inconceIvable as that presented in this study, the need tor
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accurate detection of enterococcal susceptibility patterns is apparent. Let us now look
briefly at the principles of susceptibility testing methods commonly in use in clinical
laboratories.
Antimiaobial Susceptibility Testing Methodologies The methodology
most commonly in use today is an automated detection system. The VITEK system IS
currently being used for antlmiaoblal susceptibIlity testing at Saint Anthony Medical
Center. VITEK IS an automated mlaoblology system used for rapid organism
identification and susceptibility testing. VITEK GPI cards are used for the Identification
of gam positive organisms to the species level while GPS-TA cards are used 10r
determlntng MIC values of catalase negative g-am positive cocci. The VITEK system
operates by utilizing the principles of nephelometry (measurement of light scatter due
to microbial g-owth) and colorimetry (detection of miaobial metabolism by measuring
colored end products or indicators). The VITEK Filler/Sealer fills tests cards containing
either antibiotics or reagents for specific biochemical tests with the prepared 0.5
McFarland Standard broth suspension of the organism to be tested. The filled card is
then placed Into the Aeaderllncubator where a 35 deg-ee Celsius incubation
temperature is maintained. VITEK measures the percentage of change In light
readln gs as compared to an inttial zero base line readtng. The idennncanon or MIC for
the orgamsm is then determined according to Its biochemical reactions or its gowth
rate In the presence of varying antibiotic concentrations, respectively. Inoculation of
the appropriate VITEK card determines what testing will be performed by the
instrument.
BH!lvancomycin agar is one of the confirmatory methods recommended by the
federal government for confirming automated susceptibility testing. BHllvancomycin
agar plates are a solid, enriched culture media incorporating 6 mg of the antibiotic
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Vancomycin. The plates are inoculated with a Mcfarland 0.5 Standard broth
suspension of the enterococcal isolate and are read for gowth after aerobic
incubation at 37 degrees Celsius for 24 hours. Growth of more than one individual
colony indicates vancomycin resistance while lack of g-owth indicates susceptibility to
vancomycin.
Finally, Kirby-Bauer diSKdiffusion has also been modified by NCClS fer
determining vancomycin susceptibility. The Kirby-Bauer Method is a way to measure
the 117 wro susceptibility of bacteria to antimiaobial agents. Filter- paper diSKS
containmg 30 ~g vancomycin are applied to the moist Mueller-Hinton agar surface
atter appropriate Inoculation of the agar with a 0.5 Mcfarland Standard broth
suspension of the enterococcal isolate. The vancomycin diffuses Into the surrounding
medium, presenting a gadient of vancomycin concentration as the Enterococo are
multlplymg loganthmlcally on the agar surface. The diameter of the zone ot inhibition
relates linearly to the MIC of the enterococcal isolate.
The three methodologes discussed, VITEK, BHllvancomycm agar plates, and
Kirby-Sauer disk diffUSion, will be evaluated in this study to determine their ability to
gIVe accurate susceptibility testing results fer vancomycin with respect to enterococcal
isolates from patient specimens.
As stated previously, there has been little past research concerning the efficacy
er inefficacy of these three susceptibility detection methods. One published test
conducted by the CDC in 1993 evaluated VITEK, diSKdiffusion, and another
automated technology by sending five enterococcaJ strains of known identity and
resistance to participating clinicallaberataies in New Jersey (Tenover. 1993). The
. results indicated that 96% of the labaataies correctly Identified a vanA strain as
highly resistant regardless of the susceptibility testing methodology they used
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(Tenover, 1993). In contrast, only 29% of laboratories correctly identified the vanS
strain as vancomycin resistant. 63% of VITEK users reported incorrect results as did
two of four labs using disk diffusion (which is approved as a confirmatory method)
(Tenover, 1993). With respect to the vanC isolate, none of the labs participating
identified the strain as resistant, however, 97% of VITEK users identified the resistance
as intermediate as did the CDC lab rtself (Tenover, 1993). Furthermore, another
goup of researchers who evaluated only the VITEK GPI card with version 7.1 software
concluded that. 'Detecnon of vancomycin resistance by the VITEK GPS-TA card In
Enterococci has been markedly improved and should now be considered acceptable"
(Willey 1993). In light of the ambiguous results of these two studies and the lack of
further substantiating evidence that one method of vancomycin susceptibility testing IS
superior with respect to Enterococcal isolates, let us now look at the methods and
results of the current study conducted at Saint Anthony Medical Center.
Methods One huncred-six Enterococcal isolates from clinical specimens were
obtained from several medical centers in the northern Illinois region. Vancomycin
resistant Enterococcal isolates were procured from several medical centers in order to
obtain a geater number of resistant isolates for testing. Each of the enterococcal
isolates obtained were initially frozen from pure cultures in thioglycollate broth wrth
, 0% glycerine in order to allow batch testing at a later date. Each specimen was then
thawed and streaked onto a blood agar plate to obtain fresh 24 hour g-owth while
ensuring the vlabllrty of the organism and purity of the inoculum. After 24 hours of
incubation at 37 deg-ees Celsius in 5-9% C02. colonies from each plate were
inoculated to a BHllvancomycin agar screening plate, Mueller-Hinton plate (Kirby-
Bauer method), and VITEK GPS-TA card for determining susceptibility to vancomycin.
Inoculation to the BHl/vancomycin agar plate wa$ done by making a 0.5
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McFarland standard inoculation of each isolate in a separate tube of sterile Mueller-
Hinton broth. One streak of this inoculum was then made on the surface of the agar
with several isolates being tested in different areas of one plate. The plates were then
incubated at 35 degees Celsius in an ambient air incubata- fa- 24 hours and
examined fa- gowth. Any visible gowth on the BHllvancomycin plates was
interpreted as vancomycin resistance. The Mueller-Hinton plates for Kirby-Bauer
testing were inoculated fa- confluent gowth with the same 0.05 McFarland standard in
Mueller-Hinton broth that was used fa- each isolate for the BHllvancomycin saeening
plate. A vancomycin (30 ~g) sensitivity disk was pressed onto each agar plate within
15 minutes of inoculation and the plates were incubated for 18 hours at 35 degees
Celsius in an ambient air incubator. Inhibition zone diameters were measured with
siiding caliper and susceptibility determined according to NCClS tables as follows:
isolates with a zone of inhibition ~14 mm vancomycin resistant, 15-16 mm
intermediate, and ;;:17 mm vancomycin susceptible. The VITEK GPS-TA cards (and
GPI cards for speciating vancomycin resistant isolates in order to estimate vancomycin
resistant phenotype) were inoculated acca-ding to the manufacturer'
recommendations and were evaluated with VITEK software version 8.0.
Results The overall results of the study are shown in Tables 2.3. and 4. The
BHl/vancomycin agar method identified 23 of the 106 enterococcal isolates as
vancomycin resistant. The remainder of the clinical isolates failed to gow on these
plates and were therefore identified as vancomycin susceptible. Since
BHIIVancomycin agar plates are recommended by the CDC for confirming laborata-y
determination of vancomycin resistance in Enterococci. the results obtained with Kirby-
Bauer and VITEK methodologies were evaluated in reference to the results desaibed
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above (Centers for Disease Control, 1994). Testing using Kirby-Bauer methodology
correctly identified 22 of the 23 vancomycin resistant isolates (96%) and all of the 83
vancomycin susceptible isolates (100%). The isolate misidentified as vancomycin
sensitive by the Kirby-Bauer methodology was presumptively identified as the vanC
phenotype. VITEK GPS-TA MIC determination correctly identified 20 of the 23
vancomycin resistant isolates (87%) and all of the 83 vancomycin susceptible isolates
(100%). The three isolates incorrectly IdentifIed as vancomycn senSItIve by VITEK
may be either the vanA or the vanS phenotype.
Discussion The sensitivity and specificity of each method tested are shown in
Table 5. As stated previously, there has been little past research concerning the
efficacy or inefficacy of the three susceptibility testing methods evaluated In this study,
The one published test I was able to find was conducted by the CDC in 1993 and
evaluated VITEK. disk diffusion. and another automated technology by sending fIve
enterococcal strains of known identity and susceptibility pattern to participating cllnrcal
laboratories in New Jersey (Tenover, 1993). The results of this study indicated that
96% of the laboratories correctly identified the vanA strain as highly resistant
regardless of the susceptibility testing methodology used. In contrast. only 29% of the
laboratcnes correctly identified the vanS strain as vancomycin resistant. 63% of VITEK
users reported incorrect results as did two of four labs using disk diffusion. With
respect to the vanC isolate, none of the labs participating identified the strain as
resistant; however, 97% of VITEK users identified the resistance as intermediate.
Although the present study was conducted in a different format than the CDC
study. the results of the two studies seem to correlate. Only four enterococcal isolates
were incorrectly identIfied in the present study, and there seems to be little slgnrficant
difference in the ability of VITEK and Kirby-Bauer methodologies to correctly Identify
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vancomycin resistance in EnterococcI, Although I was unable to definitively determine
the resistance phenotype of the VRE isolates using methods available to me, I was
able to base resistance phenotypes on those commonly associated with each
enterococcal species. In ag-eement with the CDC study, 15% of isolates possibly
displaying either vanA or vanS resistance phenotypes were incorrectly identified as
vancomycin sensitive by VITEK. Similarly, one of three isolates expected to display
the vane phenotype was incorrectly identified as vancomycin sensitive by Kirby-Bauer
diSKdiffusion. However, in contrast to the results of the CDC study, VITEK correctly
identified all three of the enterococcal isolates which presumptively express the vane
phenotype,
The sensitivity and specificity of each of the three methodologies evaluated In
this study are quite high. [Table 5] Whether or not these values justify using only
VITEK automated MIC determination or Kirby-Bauer susceptibility testing without a
confirmatory method can not be determined by this rather limited study alone.
However, these results do confirm that incorrect susceptibility testing results occur with
both VITEK and Kirby-Bauer methodologies, particularly in determining vancomycin
resistance. ThIS data does support the reliability of BHllvancomycin agar saeemng
plates as a confirmatory method for determining both vencomyon susceptibility and
resistance. Additionally, it should be noted that the frequency of recovering VRE in
the northern Illinois region can not be estimated on the basis of this data since
resistant isolates were collected from several medical centers and not all vancomycin
susceptible isolates recovered during the same time period were tested.
In conclusion, before clinical laboratories can rely on either VITEK or Kirby-
Bauer susceptibility testing methods alone, a larger study must be conducted. It may
be found that these two methods are unable to reliably detect certain phenotypes of
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vancomycin resistance, or that the problem in detecting enterococcal resistance to
vancomycin is more sporadic, varying with each enterococcal strain. Until additional
studies confirm that automated MIC determination or Kirby-Bauer susceptibility testing
consistently give reliable results, confirmatory testing with BHllvancomycin agar plates
will ensure that accurate vancomycin susceptibility results are reported for
enterococcal isolates,
Regardless of the results of this and future studies, the striking spread of
antimicrobial resistance in Enterococci and other pathogens will continue to plague
the treatment of infectious disease. Vancomycin resistant Enterococci are not Just a
problem for large hospitals or select patient populations; rather, this type of resistance
IS a concern for all medical centers due to the Increase in number of nosocomial
Infections caused by VRE. From the standpoint of healthcare profeSSionals, the most
disheartening result of vancomycin resistance In EnterococcI reaches beyond the
threat of spreading antimicrobial resistance to the struggle of managing patients
Infected with organisms that can not be treated effectively with any available antibiotic.
As one phYSician unambiguously stated, these patients will most likely die.
With the unbridled resurgence of many of the bacterial pathogens that formerly
posed little challenge or threat to modern antibiotic treatment, healthcare professionals
are becoming acutely aware of the inaeasing demand fer susceptibility testing of
clinical isolates. Until a new generation of antimicrobials is developed, the battle
against spreading bacterial resistance and treatment failure will continue and it is the
role of the clinical microbiology laboratory to provide prompt and reliable antimicrobial
susceptibility results.
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